SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is drawing significant community attention as investors debate whether current price consolidation offers a prime entry point or signals further downside. Supporters are heavily focused on the token's role within the Base ecosystem and potential utility integrations, while discussion remains split between calls for a massive short squeeze and concerns regarding sustained volume.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly remains a central market focus as strong demand for its GLP-1 weight-loss and diabetes franchise drives consistent institutional interest and multiple target price hikes. The community is actively debating the company's competitive position in the oral drug market and its aggressive expansion strategy through recent biotech acquisitions, while monitoring the ongoing sector rotation that continues to favor large-cap biopharma leaders.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as investors and the community closely monitor upcoming clinical data and product launches, including the expansion of Iheezo and the potential for a massive short squeeze given high institutional interest. Sentiment remains focused on the company's long-term commercial platform and potential upside from label expansions and strategic business updates.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is facing significant downward pressure from investor concerns over heavy share dilution and an upcoming reverse stock split. The community is sharply divided, with bearish voices warning of further downside and potential delisting, while some speculators are focused on Bitcoin price correlations and the stock's potential for high-risk recovery plays.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate Technology is trending as part of a broader, high-momentum rally in memory and storage stocks driven by persistent AI infrastructure demand and tight supply constraints. Community sentiment remains focused on the sector's long-term potential as a critical AI bottleneck, though traders are actively debating the sustainability of the current price surge and monitoring for potential profit-taking.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors rally around the company's strategic partnership with the U.S. Army to develop rare earth separation facilities on domestic military installations, effectively positioning it as a key player for meeting future defense supply chain requirements. The community remains highly active, debating the stock's long-term potential as a 'mine-to-magnet' solution amid sector-wide volatility and the upcoming 2027 statutory ban on Chinese-origin rare earths.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as investors debate the impact of ongoing token dilution against its long-term potential for institutional adoption in tokenized finance. Community members are actively split between those aggressively accumulating positions in anticipation of a future utility-driven breakout and others frustrated by the persistent price pressure and the project's complex tokenomics.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are closely monitoring Luckin Coffee for a potential rebound as the stock faces downward pressure amid broader Chinese equity volatility. The community remains focused on the company's aggressive international store expansion and the impact of the recently authorized share repurchase program on long-term value.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

Investors are actively debating UAMY's role as a critical sole-source supplier of antimony to the U.S. military, with community sentiment split between frustration over price volatility and bullish conviction regarding future defense contracts. The ongoing conversation centers on the company's progress in domestic mining and refining capabilities, which many hope will serve as a long-term catalyst against foreign supply dependency.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to significant attention surrounding its selective ITK inhibitor, soquelitinib, as investors track upcoming data readouts and evaluate its competitive positioning against other oral and biologic treatments in the immunology space. The community remains heavily divided, with bulls highlighting the potential for strategic partnerships or acquisition, while bears express skepticism regarding the company's long-term commercial path and the crowded nature of the biotech market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

svw007

Daniel Webb

Jean-François Ménard

Robert Ruple

Stuart Sklar

Jon mil

Jerome

StockTwits For Android 

Cleanspark Inc

Matt

@Mr_H https://www.youtube.com/watch?v=mki2mznqanU&amp;t=1s

One of the world's largest hedge funds, D.E. Shaw, just informed investors that it is extending the amount of time it will take for them to redeem their money. For a firm managing more than $90 billion, that's a major shift.